Prof. Marc Freichel

Marc, MD, is Director of the Division of General Pharmacology at Heidelberg University, Germany. He is best known for his work on the discovery of biological functions of TRP cation channels, and on the expertise of his laboratory in transgenic approaches. A main interest of his lab is the role for Ca2+ signaling, particularly in cells in the cardiovascular system, and its influence on the development of cardiac dysfunction and diabetic long-term complications.